Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 19.17B | 17.50B | 15.96B | 14.05B | 13.33B |
Gross Profit | 11.54B | 10.94B | 9.68B | 8.44B | 7.95B |
EBITDA | 2.86B | 2.59B | 2.31B | 1.73B | 2.10B |
Net Income | 854.56M | 739.69M | 846.76M | 483.62M | 1.17B |
Balance Sheet | |||||
Total Assets | 18.03B | 15.69B | 14.57B | 11.51B | 11.06B |
Cash, Cash Equivalents and Short-Term Investments | 8.46B | 6.66B | 6.68B | 4.59B | 4.67B |
Total Debt | 3.02B | 2.01B | 1.96B | 693.48M | 524.70M |
Total Liabilities | 8.54B | 7.03B | 6.62B | 4.36B | 3.77B |
Stockholders Equity | 9.46B | 8.64B | 7.93B | 7.13B | 7.00B |
Cash Flow | |||||
Free Cash Flow | 1.23B | 267.18M | 293.69M | 327.16M | 614.76M |
Operating Cash Flow | 2.81B | 2.20B | 1.68B | 1.56B | 1.90B |
Investing Cash Flow | -1.60B | -1.80B | -1.14B | -1.19B | -1.16B |
Financing Cash Flow | 280.79M | -645.92M | 763.68M | -822.04M | -64.61M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | ¥26.41B | 12.92 | 5.10% | 13.49% | 24.79% | ||
76 Outperform | ¥20.64B | 21.13 | 0.69% | 15.09% | 85.53% | ||
66 Neutral | ¥24.23B | 21.42 | 1.48% | -2.15% | -13.31% | ||
65 Neutral | ¥23.15B | 32.02 | 1.81% | 7.60% | -6.99% | ||
63 Neutral | €10.05B | 18.64 | 6.74% | 1.75% | 2.60% | -31.99% | |
59 Neutral | ¥22.51B | 40.56 | ― | -17.30% | ― |
GMO GlobalSign Holdings K.K. reported its consolidated financial results for the first quarter of 2025, showing a slight increase in net sales by 4% year-on-year to ¥4,909 million. However, the company experienced a decline in operating profit, ordinary profit, and profit attributable to owners of the parent, with decreases of 32.6%, 39.1%, and 39.6% respectively. The company’s financial position showed a slight decrease in total assets and net assets compared to the end of 2024, with a capital adequacy ratio of 50.3%. Despite these challenges, the company forecasts a positive outlook for the full fiscal year ending December 31, 2025, with expected growth in net sales and profits.